Prime Medicine's strategic collaboration with Bristol Myers provided $55 million in cash upfront. Read why I upgrade PRME stock from hold to buy.

Researchers have identified that the status of the T-cell Golgi apparatus is a key indicator of performance in cancer ...

When thinking about the immune system, most people think about B and T cells ... today in Stem Cell Reports provides evidence that brief exposure to certain danger signals can prime the body's ...

prime other immune cells like cytotoxic T cells, and strategies to overcome the immunosuppressive tumor microenvironment. Dendritic cells (DCs) are the most powerful antigen presenting cell of the ...